BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Odoux C, Albers A, Amoscato AA, Lotze MT, Wong MK. TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer. Int J Cancer. 2002;97:458-465. [PMID: 11802207 DOI: 10.1002/ijc.1640] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Yoo GH, Tran VR, Lemonnier LA, Ezzat WH, Subramanian G, Piechocki MP, Ensley JF, Lonardo F, Kim H, Lin HS. BMS-275183-induced gene expression patterns in head and neck carcinoma. Am J Otolaryngol 2007;28:309-15. [PMID: 17826531 DOI: 10.1016/j.amjoto.2006.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
2 Felber M, Sonnemann J, Beck JF. Inhibition of novel protein kinase Cɛ augments TRAIL-induced cell death in A549 lung cancer cells. Pathol Oncol Res 2007;13:295-301. [DOI: 10.1007/bf02940308] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
3 Yang N, Yao S, Liu D. Tumor necrosis factor-related apoptosis-inducing ligand additive with Iodine-131 of inhibits non-small cell lung cancer cells through promoting apoptosis. Oncol Lett 2018;16:276-84. [PMID: 29928412 DOI: 10.3892/ol.2018.8635] [Reference Citation Analysis]
4 Zhou HB, Zhu JR. Paclitaxel induces apoptosis in human gastric carcinoma cells. World J Gastroenterol 2003; 9(3): 442-445 [PMID: 12632493 DOI: 10.3748/wjg.v9.i3.442] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 29] [Article Influence: 1.2] [Reference Citation Analysis]
5 Stegehuis J, de Wilt L, de Vries E, Groen H, de Jong S, Kruyt F. TRAIL receptor targeting therapies for non-small cell lung cancer: Current status and perspectives. Drug Resistance Updates 2010;13:2-15. [DOI: 10.1016/j.drup.2009.11.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
6 Yoo GH, Piechocki MP, Oliver J, Lonardo F, Zumstein L, Lin H, Kim H, Shibuya TY, Shehadeh N, Ensley JF. Enhancement of Ad-p53 Therapy with Docetaxel in Head and Neck Cancer: . The Laryngoscope 2004;114:1871-9. [DOI: 10.1097/01.mlg.0000147914.51239.ed] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
7 Soria JC, Márk Z, Zatloukal P, Szima B, Albert I, Juhász E, Pujol JL, Kozielski J, Baker N, Smethurst D, Hei YJ, Ashkenazi A, Stern H, Amler L, Pan Y, Blackhall F. Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer. J Clin Oncol 2011;29:4442-51. [PMID: 22010015 DOI: 10.1200/JCO.2011.37.2623] [Cited by in Crossref: 172] [Cited by in F6Publishing: 98] [Article Influence: 15.6] [Reference Citation Analysis]
8 Yang LQ, Fang DC, Wang RQ, Yang SM. Effect of NF-κB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. World J Gastroenterol 2004; 10(1): 22-25 [PMID: 14695762 DOI: 10.3748/wjg.v10.i1.22] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.3] [Reference Citation Analysis]
9 Chen L, Qiu Y, Hao Z, Cai J, Zhang S, Liu Y, Zheng D. A novel humanized anti-tumor necrosis factor-related apoptosis-inducing ligand-R2 monoclonal antibody induces apoptotic and autophagic cell death. IUBMB Life 2017;69:735-44. [PMID: 28748573 DOI: 10.1002/iub.1659] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
10 Minero VG, De Stefanis D, Costelli P, Baccino FM, Bonelli G. In vitro and in vivo conditional sensitization of hepatocellular carcinoma cells to TNF-induced apoptosis by taxol. Cell Cycle 2015;14:1090-102. [PMID: 25564714 DOI: 10.1080/15384101.2014.1000695] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
11 Rubinchik S, Yu H, Woraratanadharm J, Voelkel-Johnson C, Norris JS, Dong JY. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector. Cancer Gene Ther. 2003;10:814-822. [PMID: 14605667 DOI: 10.1038/sj.cgt.7700651] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
12 Chen LH, Liu XS, Wang WY, Han WN, Pan BR, Jin BQ. Localization of TRAIL/TRAILR in fetal pancreas. World J Gastroenterol 2003; 9(2): 334-337 [PMID: 12532461 DOI: 10.3748/wjg.v9.i2.334] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
13 Rosenthal DI, Fuller CD, Machtay M, Algazy KM, Meyer DM, Kaiser LR, Yardley DA, Loiacano ME, Carbone DP. Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent with Radiation Therapy for Locally Advanced Non???Small Cell Lung Cancer: . Journal of Thoracic Oncology 2006;1:38-45. [DOI: 10.1097/01243894-200601000-00009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Odoux C, Albers A. Additive Effects of TRAIL and Paclitaxel on Cancer Cells: Implications for Advances in Cancer Therapy. TRAIL (TNF-Related Apoptosis-Inducing Ligand). Elsevier; 2004. pp. 385-407. [DOI: 10.1016/s0083-6729(04)67020-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
15 Humphreys RC, Halpern W. Trail Receptors: Targets for Cancer Therapy. Programmed Cell Death in Cancer Progression and Therapy. Dordrecht: Springer Netherlands; 2008. pp. 127-58. [DOI: 10.1007/978-1-4020-6554-5_7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
16 Liang C, Shiu L, Chang L, Sheu H, Kuo K. Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells. Mol Nutr Food Res 2007;51:999-1005. [DOI: 10.1002/mnfr.200700044] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
17 Mielgo A, Torres VA, Clair K, Barbero S, Stupack DG. Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules. Oncogene 2009;28:3551-62. [PMID: 19668227 DOI: 10.1038/onc.2009.210] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]